Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells

1 Jan 2017

Abstract excerpt

Cardiomyocytes (CMs) derived from human pluripotent stem cells (hPSCs) are considered a most promising option for cell-based cardiac repair. Hence, various protocols have been developed for differentiating hPSCs into CMs. Despite remarkable improvement in the generation of hPSC-CMs, without purification, these protocols can only generate mixed cell populations including undifferentiated hPSCs or non-CMs, which...

Source

Identifiers

PMID: 28638487
DOI: 10.7150/thno.19427

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem CellsPMID 28638487Read ↗

Generation and purification of human stem cell-derived cardiomyocytesSemantic proximity Read ↗

Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells: Current Strategies and Limitations.Semantic proximity Read ↗

Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytesSemantic proximity Read ↗

Differentiation of Cardiomyocytes from Human Pluripotent Stem Cells Using Monolayer CultureSemantic proximity Read ↗

Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.Semantic proximity Read ↗

Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell PromiseSemantic proximity Read ↗

Specific induction and long-term maintenance of high purity ventricular cardiomyocytes from human induced pluripotent stem cellsSemantic proximity Read ↗

Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells.Semantic proximity Read ↗

Embryonic template-based generation and purification of pluripotent stem cell-derived cardiomyocytes for heart repair.Semantic proximity Read ↗

Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectivesSemantic proximity Read ↗

Cardiac Differentiation of Pluripotent Stem CellsSemantic proximity Read ↗

Considerations in designing systems for large scale production of human cardiomyocytes from pluripotent stem cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.